HEATSTAR: The Detection of Heat Stress by Assessing Individual Body Responses to Heat (Heat Strain) in Young and Healthy Non-athlete Participants

Sponsor
ETH Zurich (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05622188
Collaborator
Swiss Federal Office of Sports (BASPO) (Other), Functional Genomics Center, ETH Zurich/University of Zurich (Other), Center for Chronobiology, Psychiatric University Clinics, Basel (Other), epyMetrics (Other), Innosuisse - Swiss Innovation Agency (Other), Swiss Federal Railways (Other)
20
1
3
6.8

Study Details

Study Description

Brief Summary

• This study investigates and compares the within and in-between variances of the body responses to different heat stressors in a controlled lab-setting. The participants will be exposed to different heat sources while a variety of physiological heat strain reactions such as heartrate, sweat rate, and core body temperature are recorded using on- and in-body devices. For the participant monitoring during the study, medical grade devices such as a certified ECG and a swallowable sensor-pill to continuously monitor the core body temperature will be applied. A one-for-all wearable device is additionally applied for physiological validation. Further, sweat will be collected to assess (i) the local sweat rate and (ii) the appearance of different heat stress associated molecular markers in this non-invasively collectable biofluid. As a secondary aim, a model will be developed that will enable to predict the different heat stress sources out of the heat strain measurements.

Condition or Disease Intervention/Treatment Phase
  • Other: Elevated ambient heat
  • Other: Elevated relative humidity
  • Other: Exertion

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
HEAT Stress Detection From Personally STandARdized Heat Strain Measurements - The HEATSTAR Pilot Trial
Actual Study Start Date :
Nov 2, 2022
Anticipated Primary Completion Date :
Jan 31, 2023
Anticipated Study Completion Date :
Jan 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Healthy participants

Age of the participants is between 18-40 years, females and males equally distributed

Other: Elevated ambient heat
Temporary exposure to increased ambient temperature +10°C (the effect of the intervention is fully and spontaneously reversible)

Other: Elevated relative humidity
Temporary exposure to increased ambient relative humidity +40% (max. 90%) (the effect of the intervention is fully and spontaneously reversible)

Other: Exertion
Temporary exertion on an ergometer (1W/kg body weight) (the effect of the intervention is fully and spontaneously reversible)

Outcome Measures

Primary Outcome Measures

  1. The within and between subject heat strain marker variability in relation to specific heat stress sources (ambient heat, ambient humidity, exertion, and clothing) [Max. 7 days]

    The primary endpoint is the within- and between- subject heat strain marker variability of HR, CBT, WSR, and LSR in relation to various heat stress sources (increased ambient temperature, increased relative humidity, and exertion, all without and with additional clothing.

Secondary Outcome Measures

  1. Accuracy to detect the specific heat stress source (such as ambient heat, relative humidity) from different on- and in-body measurements [Max. 7 days]

    The models for the primary endpoints will be extended to explore the relationships between heat strain parameters, heat stress sources, as well as personal characteristics. Additionally, prediction of heat stress source will be explored.

  2. Assessment of short-term heart rate variability in context to each heat stressor. [Max. 7 days]

    Short-term HRV with a repeating time frame of 5min. Root mean square of successive RR interval (RMSSD; in [ms]) and the Standard-deviation of RR intervals (SDRR; in [ms]) will be computed with respect to each heat stress source.

  3. Temperature [°C] and relative humidity [%] of the microenvironment as an additional source of information for patterns to detect heat stressors [Max. 7 days]

    Features of temperature [°C] and relative humidity [%] of the microenvironment as additional model predictors.

Other Outcome Measures

  1. The relation between cognitive assessment and skin temperature [Max. 7 days]

    Correlation between subjective heat comfort (Visual Analog Scale, where +1 is comfortable and +4 is very uncomfortable) and baseline differential stress inventory (causes of stress, symptoms of stress, coping, stress stabilization) in relation to skin temperature [°C]

  2. The relation between STROOP assessment and different heat stressors [Max. 7 days]

    Correlation between changes in the STROOP assessment outcome (number of errors and time of decision [ms], between beginning and end of heat stress exposure) in context to the various heat stress sources, skin temperature, and thermal comfort.

  3. Novel Sweat Biomarkers for heat stress detection [Max. 7 days]

    Descriptive statistics for novel non-invasive biomarkers from sweat analysis with respect to heat stress source, including between- and within-subject variability

  4. Recording heat strain parameters with an all-for-one device [Max. 7 days]

    The 'reliability' (missing data per minute ([%]) and the 'accuracy' (HR [bpm] with 95% confidence intervals), CBT (in [°C] with 95% confidence intervals), and local sweat rate measurements (in [g/h] with 95% confidence intervals) of the wearable device in recording vital parameters.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy participant, able to give consent

  • Age 18-40 years

  • Non-athlete (<4h sport/week)

  • BMI<30 (non-obese)

  • German speaking, or fluent in German

Exclusion Criteria:
  • Pregnancy (urine pregnancy test), and breastfeeding

  • Regular medication intake (excluding birth control pill)

  • Intake of drugs and/or daily alcohol consumption

  • Fever or symptoms of an acute infection (cough, shortness of breath, sore throat, taste loss)

  • Active smoking or history of smoking <9 months ago

  • Mobility impairment

  • Traveled (<1 month ago) to a warm/hot temperature zone and stayed for >6 days

  • Any chronic conditions such as: high blood pressure, diabetes mellitus, immuno-deficiencies, sweat disorders such as anhidrosis

  • Color blindness (STROOP test)

  • Weight <40 kg (e-Celsius pill)

  • Diverticulum or obstructions of the gastrointestinal tract (including motility disorders, swallowing disorders) as well as major abdominal surgery (e-Celsius pill)

  • Need of exposure to strong electromagnetic fields during study participation, above all MRI examinations (e-Celsius pill)

Contacts and Locations

Locations

Site City State Country Postal Code
1 ETH Zurich Zurich Andere (Nicht USA-Länder) Switzerland 8093

Sponsors and Collaborators

  • ETH Zurich
  • Swiss Federal Office of Sports (BASPO)
  • Functional Genomics Center, ETH Zurich/University of Zurich
  • Center for Chronobiology, Psychiatric University Clinics, Basel
  • epyMetrics
  • Innosuisse - Swiss Innovation Agency
  • Swiss Federal Railways

Investigators

  • Principal Investigator: Noé Brasier, MD, ETH Zurich

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Noe Brasier, Principal Investigator, ETH Zurich
ClinicalTrials.gov Identifier:
NCT05622188
Other Study ID Numbers:
  • EKNZ ID: 2022 - 01325
First Posted:
Nov 18, 2022
Last Update Posted:
Jan 11, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Noe Brasier, Principal Investigator, ETH Zurich
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2023